DEC-C (oral decitabine/cedazuridine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DEC-C (oral decitabine/cedazuridine), covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma [Phase 1, Phase 2]